Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Common Equity (2017 - 2025)

Cirtran's Common Equity history spans 14 years, with the latest figure at -$25.1 million for Q4 2025.

  • Quarterly results put Common Equity at -$25.1 million for Q4 2025, down 2.87% from a year ago — trailing twelve months through Dec 2025 was -$25.1 million (down 2.87% YoY), and the annual figure for FY2025 was -$25.1 million, down 2.87%.
  • Common Equity for Q4 2025 was -$25.1 million at Cirtran, up from -$25.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$21.8 million in Q4 2023 to a low of -$43.0 million in Q3 2023.
  • The 5-year median for Common Equity is -$40.7 million (2021), against an average of -$33.7 million.
  • The sharpest move saw Common Equity soared 48.23% in 2023, then fell 12.06% in 2024.
  • Year by year, Common Equity stood at -$40.6 million in 2021, then fell by 3.7% to -$42.1 million in 2022, then soared by 48.23% to -$21.8 million in 2023, then fell by 12.06% to -$24.4 million in 2024, then dropped by 2.87% to -$25.1 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at -$25.1 million, -$25.5 million, and -$25.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.